Chemical Structure (Brivaracetam 01)
Brivaracetam Injection
Product Images NDC 14335-420
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 14335-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Brivaracetam 02)
This text provides information about a study involving different dosages of BRIVIACT (50mg/day, 100mg/day, and 200mg/day) compared to Placebo in a sample of participants. The study also shows the reduction in seizure frequency from baseline in percentage.*
Principal Display Panel (50 mg/5 mL Vial Carton)
This is information about Brivaracetam Injection, a medication with a concentration of 50 mg/5 mL for intravenous use. The medication comes in single-dose vials and must be stored at room temperature. The inactive ingredients include sodium acetate, glacial acetic acid, sodium chloride, and water for injection. The usual dosage should be followed as per accompanying prescribing information. Unused portions should be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
